At a glance
ClinicalIndex Comparison RecordN/ACompleted· 212 enrolled
Drug / intervention
Sutent: Observational Studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Patterns Of Care Among Australian Cohort Of Patients With Advanced Rrc Receiving Sutent
In Brief
An observational study evaluating Sutent: Observational Study for Metastatic Renal Cell Carcinoma. Completed, enrolled 212 participants.
Detailed Summary
This is a retrospective, non-interventional study which looks at the cohort of Renal Cell Carcinoma patients in a real life clinical setting and analyses into factors why these patients have been surviving for as long as 3-5 years unlike Clinical study where the survival is around 2 years. The factors which will be analysed include patient characteristics, dosage and adverse event management and tries to correlate these factors with survival.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMetastatic Renal Cell Carcinoma
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartAug 2013
First PostedAug 2013
Primary CompletionMar 2014
TodayJul 2026
First PostedAug 6, 2013
Enrollment StartAug 1, 2013
Primary CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 12.9 years ago
Interventions
Sutent: Observational Studyother
Sutent oral therapy